SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-038956
Filing Date
2021-06-08
Accepted
2021-06-08 16:53:35
Documents
2
Period of Report
2021-06-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1559
2 POA DOCUMENT poa.txt EX-24.3_991283 3043
  Complete submission text file 0001209191-21-038956.txt   5984
Mailing Address C/O TOBIRA THERAPEUTICS, INC. 701 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Brosgart Carol L (Reporting) CIK: 0001614724 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38981 | Film No.: 211002734

Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Issuer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations